Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia — Stella

Home/Aplastic Anemia/CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

View on ClinicalTrials.gov

Recruiting

Back to Aplastic Anemia trials

CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

The First Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou, Zhejiang

Key details

Phase

Very early testing

Sponsor

Zhejiang University

Collaborators

Yake Biotechnology Ltd.

Enrollment target

~30 participants

Started

October 2024

Primary completion

October 2027

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.